A Comparative Cross-Sectional Study of Serum Calreticulin and ESR in Rheumatoid Arthritis and Its Correlation with Disease Activity
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.134 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Neethu D. S. und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by persistent inflammation, progressive joint destruction, and extra-articular manifestations. The present study aimed to compare serum calreticulin and ESR levels between RA patients and healthy controls and to evaluate their association with disease activity. Materials and Methods: Study comprises a total of 100 participants comprising 50 patients with rheumatoid arthritis came to Medicine department, M.Y. Hospital, Indore, Madhya Pradesh, India and 50 age and gender matched healthy controls. Participants are enrolled as per inclusion criteria. Disease activity was assessed using DAS28-ESR. Serum calreticulin levels were measured by ELISA, while ESR was estimated using the standard method.
Results
Serum Calreticulin and ESR demonstrated a progressive increase from remission to high disease activity. Serum calreticulin showed a strong positive correlation with DAS28 across all disease activity categories, including remission and low disease activity, whereas ESR showed relatively weaker association in remission. Serum calreticulin also correlated positively with ESR.
Conclusion
We conclude that, compared with ESR, calreticulin appears to be a more sensitive biomarker and potentially useful as an adjunct marker for disease activity assessment and monitoring in rheumatoid arthritis.
Zitieren
APA
S., N. D., Paneri, S., Shahi, D., Dubey, S., & Lohokare, R. (2026). A Comparative Cross-Sectional Study of Serum Calreticulin and ESR in Rheumatoid Arthritis and Its Correlation with Disease Activity. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.134
Vancouver
S. ND, Paneri S, Shahi D, Dubey S, Lohokare R. A Comparative Cross-Sectional Study of Serum Calreticulin and ESR in Rheumatoid Arthritis and Its Correlation with Disease Activity. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.134
BibTeX
@article{S2026,
author = {S., Neethu D. and Paneri, Sangita and Shahi, Deepasha and Dubey, Sanjay and Lohokare, Rajeev},
title = {A Comparative Cross-Sectional Study of Serum Calreticulin and ESR in Rheumatoid Arthritis and Its Correlation with Disease Activity},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.134}
}
EUVIMED